,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,328,1,1,,136721,7265,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,421,1,3,,17389363,7265,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
2,426,1,2,,17389363,7265,Inconclusive,,,,,Cell Viability - Jurkat,Confirmatory,,
3,427,1,1,,17389363,7265,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
4,433,1,1,,17389363,7265,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
5,434,1,2,,17389363,7265,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
6,435,1,2,,17389363,7265,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
7,445,3,1,,17389363,7265,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
8,530,1,1,,17389363,7265,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
9,540,1,1,,17389363,7265,Inconclusive,,,,,Cell Viability - N2a,Confirmatory,,
10,541,1,1,,17389363,7265,Inconclusive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
11,542,1,1,,17389363,7265,Inconclusive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
12,543,1,1,,17389363,7265,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
13,544,2,1,,17389363,7265,Active,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
14,545,1,1,,17389363,7265,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
15,546,1,1,,17389363,7265,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
16,584,1,3,,17389363,7265,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
17,585,1,4,,17389363,7265,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
18,595,1,3,,17389363,7265,Inconclusive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
19,596,1,2,,17389363,7265,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
20,603,1,2,,17389363,7265,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
21,605,1,2,,17389363,7265,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
22,654,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
23,655,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
24,656,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
25,657,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
26,658,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
27,659,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
28,660,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
29,661,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
30,662,1,1,,17389363,7265,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
31,663,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
32,664,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
33,665,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
34,666,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
35,667,1,1,,17389363,7265,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
36,875,1,2,,17389363,7265,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
37,880,2,1,,17389363,7265,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
38,880,2,1,,17389363,7265,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
39,881,2,2,,17389363,7265,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
40,884,1,2,,17389363,7265,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
41,885,1,2,,17389363,7265,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
42,886,1,2,,17389363,7265,Inconclusive,122921310.0,,2.5119,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
43,886,1,2,,17389363,7265,Inconclusive,122921311.0,,2.5119,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
44,887,1,2,,17389363,7265,Active,1832253.0,246.0,1.5849,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
45,889,1,3,,17389363,7265,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
46,892,1,2,,17389363,7265,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
47,893,1,2,,17389363,7265,Inconclusive,122921310.0,,39.8107,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
48,893,1,2,,17389363,7265,Inconclusive,122921311.0,,39.8107,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
49,894,2,1,,17389363,7265,Active,31542939.0,3248.0,10.0,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
50,900,1,3,,17389363,7265,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
51,902,1,2,,17389363,7265,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
52,912,1,2,,17389363,7265,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
53,921,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
54,923,1,2,,17389363,7265,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
55,924,1,2,,17389363,7265,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
56,925,1,2,,17389363,7265,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
57,926,1,2,,17389363,7265,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
58,938,1,2,,17389363,7265,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
59,946,1,2,,17389363,7265,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
60,947,1,2,,17389363,7265,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
61,948,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
62,955,1,2,,17389363,7265,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
63,960,1,2,,17389363,7265,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
64,961,1,2,,17389363,7265,Inconclusive,,,6.3096,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
65,962,1,2,,17389363,7265,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
66,963,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
67,964,1,2,,17389363,7265,Inconclusive,,,1.0,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
68,965,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
69,966,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
70,967,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
71,968,1,2,,17389363,7265,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-009,Confirmatory,,
72,969,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
73,970,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
74,971,1,2,,17389363,7265,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-015,Confirmatory,,
75,972,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
76,973,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
77,974,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
78,975,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
79,976,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
80,977,1,2,,17389363,7265,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-002,Confirmatory,,
81,978,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
82,979,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
83,980,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
84,981,1,2,,17389363,7265,Inconclusive,,,10.0,Potency,Cell Viability - LYMP2-010,Confirmatory,,
85,982,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
86,983,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
87,984,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
88,985,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
89,986,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
90,987,1,2,,17389363,7265,Inconclusive,,,7.9433,Potency,Cell Viability - LYMP2-022,Confirmatory,,
91,988,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
92,989,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
93,993,1,2,,17389363,7265,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
94,994,1,2,,17389363,7265,Inconclusive,,,15.8489,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
95,995,1,2,,17389363,7265,Inconclusive,66932916.0,5594.0,31.6228,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
96,1030,2,1,,17389363,7265,Active,30582681.0,216.0,8.9125,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
97,1452,1,1,,17389363,7265,Active,154426292.0,239.0,19.9526,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
98,1457,1,1,,17389363,7265,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
99,1458,1,1,,17389363,7265,Inactive,10937869.0,6607.0,28.1838,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
100,1469,1,1,,17389363,7265,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
101,1471,2,1,,17389363,7265,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
102,1476,2,1,,17389363,7265,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
103,1477,1,1,,17389363,7265,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
104,1478,2,1,,17389363,7265,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
105,1479,1,2,,17389363,7265,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
106,1948,1,1,,17389363,7265,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
107,2101,1,1,,17389363,7265,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
108,2107,1,1,,17389363,7265,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
109,2112,1,1,,17389363,7265,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
110,2120,1,1,,17389363,7265,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
111,2517,2,1,,17389363,7265,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
112,2546,1,1,,17389363,7265,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
113,2549,1,1,,17389363,7265,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
114,2551,1,1,,17389363,7265,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
115,307625,3,4,,103555833,7265,Unspecified,,,,,"Partition coefficient, log P of the compound",Other,17482318.0,
116,307626,8,1,,103555833,7265,Unspecified,,,,,Solubility in water,Other,17482318.0,
117,485290,1,1,,17389363,7265,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
118,588513,1,1,,17389363,7265,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
119,588514,1,1,,17389363,7265,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
120,588515,1,1,,17389363,7265,Inconclusive,124375976.0,367.0,11.2202,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
121,588516,1,1,,17389363,7265,Inconclusive,124375976.0,367.0,25.1189,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
122,588526,1,1,,17389363,7265,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
123,588527,1,1,,17389363,7265,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
124,588532,1,1,,17389363,7265,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
125,588533,1,1,,17389363,7265,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
126,588534,1,1,,17389363,7265,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
127,588535,1,1,,17389363,7265,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
128,588536,1,1,,17389363,7265,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
129,588537,1,1,,17389363,7265,Inconclusive,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
130,588541,1,1,,17389363,7265,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
131,588543,1,1,,17389363,7265,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
132,588544,1,1,,17389363,7265,Inconclusive,325495497.0,6256.0,22.3872,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
133,588545,1,1,,17389363,7265,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
134,588546,1,1,,17389363,7265,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
135,588547,1,1,,17389363,7265,Inconclusive,189491771.0,7068.0,39.8107,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
136,588812,1,1,,17389363,7265,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
137,588812,1,1,1.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
138,588812,1,1,2.0,17389363,7265,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
139,588812,1,1,3.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
140,588812,1,1,4.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
141,588812,1,1,5.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
142,588812,1,1,6.0,17389363,7265,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
143,588812,1,1,7.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
144,588812,1,1,8.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
145,588812,1,1,9.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
146,588812,1,1,10.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
147,588812,1,1,11.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
148,588812,1,1,12.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
149,588812,1,1,13.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
150,588812,1,1,14.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
151,588812,1,1,15.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
152,588812,1,1,16.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
153,588812,1,1,17.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
154,588812,1,1,18.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
155,588812,1,1,19.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
156,588812,1,1,20.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
157,588812,1,1,21.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
158,588812,1,1,22.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
159,588812,1,1,23.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
160,588812,1,1,24.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
161,588812,1,1,25.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
162,588812,1,1,26.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
163,588812,1,1,27.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
164,588812,1,1,28.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
165,588812,1,1,29.0,17389363,7265,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
166,588812,1,1,30.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
167,588812,1,1,31.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
168,588812,1,1,32.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
169,588812,1,1,33.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
170,588812,1,1,34.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
171,588812,1,1,35.0,17389363,7265,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
172,588812,1,1,36.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
173,588812,1,1,37.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
174,588812,1,1,38.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
175,588812,1,1,39.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
176,588812,1,1,40.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
177,588812,1,1,41.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
178,588812,1,1,42.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
179,588812,1,1,43.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
180,588812,1,1,44.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
181,588812,1,1,45.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
182,588812,1,1,46.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
183,588812,1,1,47.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
184,588812,1,1,48.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
185,588812,1,1,49.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
186,588812,1,1,50.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
187,588812,1,1,51.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
188,588812,1,1,52.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
189,588812,1,1,53.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
190,588812,1,1,54.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
191,588812,1,1,55.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
192,588812,1,1,56.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
193,588812,1,1,57.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
194,588812,1,1,58.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
195,588812,1,1,59.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
196,588812,1,1,60.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
197,588812,1,1,61.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
198,588812,1,1,62.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
199,588812,1,1,63.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
200,588812,1,1,64.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
201,588812,1,1,65.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
202,588812,1,1,66.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
203,588812,1,1,67.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
204,588812,1,1,68.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
205,588812,1,1,69.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
206,588812,1,1,70.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
207,588812,1,1,71.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
208,588812,1,1,72.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
209,588812,1,1,73.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
210,588812,1,1,74.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
211,588812,1,1,75.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
212,588812,1,1,76.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
213,588812,1,1,77.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
214,588812,1,1,78.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
215,588812,1,1,79.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
216,588812,1,1,80.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
217,588812,1,1,81.0,17389363,7265,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
218,588813,1,1,,17389363,7265,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
219,588813,1,1,1.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
220,588813,1,1,2.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
221,588813,1,1,3.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
222,588813,1,1,4.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
223,588813,1,1,5.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
224,588813,1,1,6.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
225,588813,1,1,7.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
226,588813,1,1,8.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
227,588813,1,1,9.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
228,588813,1,1,10.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
229,588813,1,1,11.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
230,588813,1,1,12.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
231,588813,1,1,13.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
232,588813,1,1,14.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
233,588813,1,1,15.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
234,588813,1,1,16.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
235,588813,1,1,17.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
236,588813,1,1,18.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
237,588813,1,1,19.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
238,588813,1,1,20.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
239,588813,1,1,21.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
240,588813,1,1,22.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
241,588813,1,1,23.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
242,588813,1,1,24.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
243,588813,1,1,25.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
244,588813,1,1,26.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
245,588813,1,1,27.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
246,588813,1,1,28.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
247,588813,1,1,29.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
248,588813,1,1,30.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
249,588813,1,1,31.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
250,588813,1,1,32.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
251,588813,1,1,33.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
252,588813,1,1,34.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
253,588813,1,1,35.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
254,588813,1,1,36.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
255,588813,1,1,37.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
256,588813,1,1,38.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
257,588813,1,1,39.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
258,588813,1,1,40.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
259,588813,1,1,41.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
260,588813,1,1,42.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
261,588813,1,1,43.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
262,588813,1,1,44.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
263,588813,1,1,45.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
264,588813,1,1,46.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
265,588813,1,1,47.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
266,588813,1,1,48.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
267,588813,1,1,49.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
268,588813,1,1,50.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
269,588813,1,1,51.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
270,588813,1,1,52.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
271,588813,1,1,53.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
272,588813,1,1,54.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
273,588813,1,1,55.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
274,588813,1,1,56.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
275,588813,1,1,57.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
276,588813,1,1,58.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
277,588813,1,1,59.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
278,588813,1,1,60.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
279,588813,1,1,61.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
280,588813,1,1,62.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
281,588813,1,1,63.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
282,588813,1,1,64.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
283,588813,1,1,65.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
284,588813,1,1,66.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
285,588813,1,1,67.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
286,588813,1,1,68.0,17389363,7265,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
287,588813,1,1,69.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
288,588813,1,1,70.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
289,588813,1,1,71.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
290,588813,1,1,72.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
291,588813,1,1,73.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
292,588813,1,1,74.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
293,588813,1,1,75.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
294,588813,1,1,76.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
295,588813,1,1,77.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
296,588813,1,1,78.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
297,588813,1,1,79.0,17389363,7265,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
298,588813,1,1,80.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
299,588813,1,1,81.0,17389363,7265,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
300,588834,2,1,,17389363,7265,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
301,651631,4,1,,144208245,7265,Active,269849759.0,7157.0,26.4198,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
302,651632,4,1,,144208245,7265,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
303,651633,4,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
304,651634,4,1,,144208245,7265,Active,,,23.5467,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
305,651741,1,1,,17389363,7265,Active,20149576.0,4780.0,10.5909,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
306,651743,1,1,,17389363,7265,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
307,651749,1,1,,17389363,7265,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
308,651751,1,1,,17389363,7265,Inconclusive,5702233.0,84385.0,56.2341,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
309,651754,1,1,,17389363,7265,Active,,,29.8493,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
310,651755,1,1,,17389363,7265,Active,,,33.4915,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
311,651757,1,1,,17389363,7265,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
312,651758,1,1,,17389363,7265,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
313,651777,1,1,,17389363,7265,Active,51095037.0,196.0,44.6684,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
314,651778,1,1,,17389363,7265,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
315,651802,1,1,,17389363,7265,Inactive,49066040.0,6097.0,,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
316,651838,1,1,,17389363,7265,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
317,651838,1,1,1.0,17389363,7265,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
318,651838,1,1,2.0,17389363,7265,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
319,651838,1,1,3.0,17389363,7265,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
320,651838,1,1,4.0,17389363,7265,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
321,651838,1,1,5.0,17389363,7265,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
322,651838,1,1,6.0,17389363,7265,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
323,651838,1,1,7.0,17389363,7265,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
324,651838,1,1,8.0,17389363,7265,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
325,720516,2,1,,144208245,7265,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
326,720552,2,1,,144208245,7265,Active,269849759.0,7157.0,27.9853,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
327,720634,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
328,720635,2,1,,144208245,7265,Active,,,9.3741,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
329,720636,1,1,,17389363,7265,Active,20149576.0,4780.0,21.1317,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
330,720637,2,1,,144208245,7265,Inconclusive,,,9.37411,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
331,720652,1,1,,17389363,7265,Inconclusive,,,66.8242,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
332,720653,1,1,,17389363,7265,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
333,720659,1,1,,17389363,7265,Inconclusive,325495557.0,8856.0,35.4813,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
334,720674,2,2,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
335,720675,2,2,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
336,720678,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
337,720679,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
338,720680,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
339,720681,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
340,720682,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
341,720683,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
342,720684,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
343,720685,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
344,720686,2,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
345,720687,2,2,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
346,720691,4,1,,144208245,7265,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
347,720692,3,1,,144208245,7265,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
348,720693,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
349,720719,2,1,,144208245,7265,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
350,720725,2,1,,144208245,7265,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
351,743012,3,1,,144208245,7265,Active,,,14.857000000000001,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
352,743014,3,1,,144208245,7265,Active,,,14.857000000000001,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
353,743015,3,1,,144208245,7265,Active,,,9.3741,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
354,743033,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
355,743035,2,1,,144208245,7265,Inconclusive,124375976.0,367.0,14.9819,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
356,743036,2,1,,144208245,7265,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
357,743040,3,1,,144208245,7265,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
358,743041,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
359,743042,3,1,,144208245,7265,Active,124375976.0,367.0,29.6436,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
360,743053,2,1,,144208245,7265,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
361,743054,2,1,,144208245,7265,Active,124375976.0,367.0,27.4535,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
362,743063,2,1,,144208245,7265,Inconclusive,124375976.0,367.0,29.8928,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
363,743064,3,1,,144208245,7265,Active,,,23.5467,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
364,743065,3,1,,144208245,7265,Active,399498506.0,24831.0,59.1467,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
365,743066,3,1,,144208245,7265,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
366,743067,2,1,,144208245,7265,Inconclusive,399498506.0,24831.0,54.7768,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
367,743069,2,1,,144208245,7265,Inactive,348019627.0,2099.0,37.6329,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
368,743074,2,1,,144208245,7265,Inconclusive,,,59.6441,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
369,743075,2,1,,144208245,7265,Inactive,348019627.0,2099.0,0.1886,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
370,743077,2,1,,144208245,7265,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
371,743078,2,1,,144208245,7265,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
372,743079,3,1,,144208245,7265,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
373,743080,3,1,,144208245,7265,Active,348019627.0,2099.0,7.4461,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
374,743081,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
375,743083,3,1,,144208245,7265,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
376,743084,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
377,743085,3,1,,144208245,7265,Active,51095037.0,196.0,29.6436,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
378,743086,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
379,743091,2,1,,144208245,7265,Active,348019627.0,2099.0,7.44612,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
380,743094,3,1,,144208245,7265,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
381,743122,2,1,,144208245,7265,Active,51095037.0,196.0,37.319,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
382,743139,2,1,,144208245,7265,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
383,743140,2,1,,144208245,7265,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
384,743191,3,1,,144208245,7265,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
385,743194,3,1,,144208245,7265,Inconclusive,,,47.376999999999995,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
386,743199,2,1,,144208245,7265,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
387,743202,4,1,,144208245,7265,Inconclusive,20149576.0,4780.0,1.3241,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
388,743203,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
389,743209,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
390,743210,4,1,,144208245,7265,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
391,743211,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
392,743212,3,1,,144208245,7265,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
393,743213,3,1,,144208245,7265,Inconclusive,,,0.1498,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
394,743215,3,1,,144208245,7265,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
395,743217,3,1,,144208245,7265,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
396,743218,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
397,743219,3,1,,144208245,7265,Active,20149576.0,4780.0,3.2008400000000004,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
398,743220,3,1,,144208245,7265,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
399,743221,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
400,743222,3,1,,144208245,7265,Inconclusive,216409708.0,7421.0,3.7633,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
401,743223,3,1,,144208245,7265,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
402,743224,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
403,743225,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
404,743226,2,1,,144208245,7265,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
405,743227,2,1,,144208245,7265,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
406,743228,3,1,,144208245,7265,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
407,743239,2,1,,144208245,7265,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
408,743240,2,1,,144208245,7265,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
409,743241,2,1,,144208245,7265,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
410,743242,2,1,,144208245,7265,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
411,743288,1,1,,17389363,7265,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
412,743292,1,1,,17389363,7265,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
413,1159509,1,1,,144208245,7265,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
414,1159515,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
415,1159516,1,1,,144208245,7265,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
416,1159517,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
417,1159518,1,1,,144208245,7265,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
418,1159519,1,1,,144208245,7265,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
419,1159520,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
420,1159521,1,1,,144208245,7265,Inactive,15928672.0,19885.0,0.2099,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
421,1159523,1,1,,144208245,7265,Inconclusive,15928672.0,19885.0,4.69819,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
422,1159525,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
423,1159526,1,1,,144208245,7265,Inconclusive,119627033.0,3725.0,47.376999999999995,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
424,1159527,1,1,,144208245,7265,Inconclusive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
425,1159528,1,1,,144208245,7265,Active,119627033.0,3725.0,42.2248,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
426,1159529,1,1,,144208245,7265,Inconclusive,,,7.5087,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
427,1159531,1,1,,144208245,7265,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
428,1159551,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
429,1159552,1,1,,144208245,7265,Inconclusive,325495463.0,5914.0,2.642,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
430,1159553,2,1,,144208245,7265,Inconclusive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
431,1159555,1,1,,144208245,7265,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
432,1224834,3,1,,144208245,7265,Active,,,33.2606,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
433,1224835,1,1,,144208245,7265,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
434,1224836,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
435,1224837,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
436,1224838,1,1,,144208245,7265,Inactive,66775687.0,9970.0,46.9819,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
437,1224839,1,1,,144208245,7265,Active,66775687.0,9970.0,52.7145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
438,1224840,3,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
439,1224841,3,1,,144208245,7265,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
440,1224842,3,1,,144208245,7265,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
441,1224843,1,1,,144208245,7265,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
442,1224844,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
443,1224845,1,1,,144208245,7265,Inconclusive,344243002.0,100757539.0,77.4238,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
444,1224846,1,1,,144208245,7265,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
445,1224847,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
446,1224848,3,1,,144208245,7265,Active,325495545.0,2101.0,29.6436,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
447,1224849,3,1,,144208245,7265,Inactive,325495545.0,2101.0,29.6436,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
448,1224867,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
449,1224868,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
450,1224869,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
451,1224870,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
452,1224871,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
453,1224872,1,1,,144208245,7265,Inconclusive,,,53.1578,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
454,1224873,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
455,1224874,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
456,1224875,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
457,1224876,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
458,1224877,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
459,1224878,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
460,1224879,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
461,1224880,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
462,1224881,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
463,1224882,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
464,1224883,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
465,1224884,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
466,1224885,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
467,1224886,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
468,1224887,1,1,,144208245,7265,Inconclusive,,,26.642,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
469,1224888,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
470,1224889,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
471,1224890,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
472,1224892,1,1,,144208245,7265,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
473,1224893,1,1,,144208245,7265,Inconclusive,66775687.0,9970.0,33.2606,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
474,1224894,1,1,,144208245,7265,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
475,1224895,1,1,,144208245,7265,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
476,1224896,1,1,,144208245,7265,Active,344243002.0,100757539.0,56.9562,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
477,1259241,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
478,1259242,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
479,1259243,1,1,,144208245,7265,Active,124375976.0,367.0,33.2606,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
480,1259244,1,1,,144208245,7265,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
481,1259247,1,1,,144208245,7265,Active,124375976.0,367.0,33.2606,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
482,1259248,1,1,,144208245,7265,Inconclusive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
483,1259364,1,1,,144208245,7265,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
484,1259365,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
485,1259366,1,1,,144208245,7265,Active,,,59.1467,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
486,1259367,1,1,,144208245,7265,Active,,,29.6436,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
487,1259368,1,1,,144208245,7265,Inactive,109731339.0,2737.0,66.3637,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
488,1259369,1,1,,144208245,7265,Active,109731339.0,2737.0,1.6669999999999998,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
489,1259377,1,1,,144208245,7265,Inconclusive,54288833.0,2100.0,14.857000000000001,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
490,1259378,1,1,,144208245,7265,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
491,1259379,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
492,1259380,1,1,,144208245,7265,Inconclusive,,,13.2413,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
493,1259381,1,1,,144208245,7265,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
494,1259382,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
495,1259383,1,1,,144208245,7265,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
496,1259384,1,1,,144208245,7265,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
497,1259385,1,1,,144208245,7265,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
498,1259386,1,1,,144208245,7265,Inconclusive,,,52.7145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
499,1259387,1,1,,144208245,7265,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
500,1259388,1,1,,144208245,7265,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
501,1259390,1,1,,144208245,7265,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
502,1259391,1,1,,144208245,7265,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
503,1259392,1,1,,144208245,7265,Active,109731339.0,2737.0,2.18071,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
504,1259393,1,1,,144208245,7265,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
505,1259394,1,1,,144208245,7265,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
506,1259395,1,1,,144208245,7265,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
507,1259396,1,1,,144208245,7265,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
508,1259401,1,1,,144208245,7265,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
509,1259402,1,1,,144208245,7265,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
510,1259403,1,1,,144208245,7265,Inconclusive,325495545.0,2101.0,39.5303,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
511,1259404,1,1,,144208245,7265,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
512,1259407,1,1,,363902529,7265,Active,,,,,CCRIS mutagenicity studies,Other,,
513,1259411,1,1,,363902529,7265,Active,,,,,CCRIS carcinogenicity studies,Other,,
